Engineered Multivalent Nanobodies Efficiently Neutralize SARS-CoV-2 Omicron Subvariants BA.1, BA.4/5, XBB.1 and BQ.1.1.

Wang, Jiali; Shi, Bingjie; Chen, Hanyi; Yu, Mengyuan; Wang, Peipei; Qian, Zhaohui; Hu, Keping; Wang, Jianxun.

Afiliação

Wang J; School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
Shi B; School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
Chen H; School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
Yu M; School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
Wang P; School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China.
Qian Z; NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Hu K; The Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Wang J; Andes Antibody Technology Hengshui LL Company, Hengshui 053000, China.

Vaccines (Basel) ; 12(4)2024 Apr 15.

Article em En | MEDLINE | ID: mdl-38675799